Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia
| Autor: | Mamoru Watanabe, Yasuo Suzuki, Toshifumi Hibi, Wai K. Leung, Katsuyoshi Matsuoka, Pin Jin Hu, Suk-Kyun Yang, Zhihua Ran, Siew C. Ng, Hyo Jong Kim, Jose D. Sollano, Choon Jin Ooi, Akira Andoh, Ida Hilmi, Shu-Chen Wei, Kaichun Wu, Vineet Ahuja, Jiaming Qian, Minhu Chen, Dong Soo Han, Yoon Tae Jeen |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty Asia Pacific Islands INTESTINAL TUBERCULOSIS digestive system Gastroenterology Inflammatory bowel disease Diagnosis Differential 03 medical and health sciences 0302 clinical medicine Asia pacific Crohn Disease Adrenal Cortex Hormones Pregnancy Internal medicine Azathioprine Asian country medicine Humans Colitis Societies Medical Monitoring Physiologic Crohn's disease Hepatology business.industry Remission Induction medicine.disease Aminosalicylic Acid digestive system diseases Natural history Methotrexate Tuberculosis Gastrointestinal 030220 oncology & carcinogenesis Practice Guidelines as Topic Colitis Ulcerative Female 030211 gastroenterology & hepatology business Immunosuppressive Agents |
| Zdroj: | Journal of Gastroenterology and Hepatology. 36:637-645 |
| ISSN: | 1440-1746 0815-9319 |
| Popis: | Inflammatory bowel disease (IBD) has increased in incidence and prevalence in Asian countries since the end of the 20th century. Moreover, differences in the cause, phenotypes, and natural history of IBD between the East and West have been recognized. Therefore, the Asian Organization for Crohn's and Colitis and the Asia Pacific Association of Gastroenterology have established recommendations on medical management of IBD in Asia. Initially, the committee members drafted 40 recommendations, which were then assessed according to Grading of Recommendations Assessment, Development and Evaluation. Eight statements were rejected as this indicated that consensus had not been reached. The recommendations encompass pretreatment evaluation; medical management of active IBD; medical management of IBD in remission; management of IBD during the periconception period and pregnancy; surveillance strategies for colitis-associated cancer; monitoring side effects of thiopurines and methotrexate; and infections in IBD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text